Holen Sie sich die Stockscreener-App
0.3574
2.55%
0.0089
Finanzdaten der Pharmacyte Biotech Inc-Aktie (PMCB)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-07-31 | 2026-04-30 | 2026-01-31 | 2025-10-31 | 2025-07-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | - |
| Operating Expenses |
59.91%
1.0067
|
2.5113 | 2.1181 | 1.3761 | 0.8483 |
| Operating Income/Loss |
59.91%
-1.0067
|
-2.5113 | -2.1181 | -1.3761 | -0.8483 |
| Nonoperating Income/Loss |
116.48%
-4.0745
|
-1.8822 | 2.865 | -6.0419 | -7.5118 |
| Income Tax Expense/Benefit |
-
|
- | - | - | - |
Net Income/Loss
|
15.65%
-5.0812
|
-4.3934 | 0.7469 | -7.418 | -8.3601 |
| Basic Average Shares |
10.74
|
- | 9.2628 | 6.7958 | 6.7958 |
| Diluted Average Shares |
10.74
|
- | 9.2628 | 6.7958 | 6.7958 |
| Basic Earnings Per Share |
-0.54
|
- | -0.17 | -1.24 | -1.23 |
| Diluted Earnings Per Share |
-0.54
|
- | -0.17 | -1.24 | -1.23 |
| Undistributed Earnings/Loss Allocated To Participating Securities, Basic |
18.72%
-5.7858
|
-4.8734 | -1.5563 | -8.4166 | -8.3601 |
1.35%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):